ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,297
Diagnostic referrals
1,010
Outstanding pathways
306

Screening pathway

  1. Screening5,297Encounters
  2. Positive finding1,851Documented findings
  3. Referral1,010Diagnostic referrals
  4. Follow-up1,260Diagnostic visits
  5. Outcome704Resolved pathways

Stage totals use different units. Pending pathways: 306. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1817 · EXP-1817Synthetic · Site D

Full participant history through 2027-04-21, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA positive
  4. · Diagnostic referral · EXP-1817-T-R
  5. · Contact attempt · Reached
  6. · Barrier documented · Transport difficulty
  7. · Diagnostic booking · Initial booking
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-03-04
  13. · Follow-up disposition · Resolved · EXP-1817-T-R
  14. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  15. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1873 · Expanded synthetic participant 1873Site C — Rural Outreach Programme
EXP-1874 · Expanded synthetic participant 1874Site C — Rural Outreach Programme
EXP-1875 · Expanded synthetic participant 1875Site A — Urban Referral Hub
EXP-1876 · Expanded synthetic participant 1876Site C — Rural Outreach Programme
EXP-1877 · Expanded synthetic participant 1877Site D — Community Engagement Programme
EXP-1878 · Expanded synthetic participant 1878Site C — Rural Outreach Programme
EXP-1880 · Expanded synthetic participant 1880Site E — Resource-Constrained Navigation Programme
EXP-1881 · Expanded synthetic participant 1881Site C — Rural Outreach Programme
EXP-1882 · Expanded synthetic participant 1882Site D — Community Engagement Programme
EXP-1883 · Expanded synthetic participant 1883Site A — Urban Referral Hub
EXP-1884 · Expanded synthetic participant 1884Site A — Urban Referral Hub
EXP-1885 · Expanded synthetic participant 1885Site B — Peri-Urban Access Programme
EXP-1886 · Expanded synthetic participant 1886Site B — Peri-Urban Access Programme
EXP-1887 · Expanded synthetic participant 1887Site A — Urban Referral Hub
EXP-1888 · Expanded synthetic participant 1888Site B — Peri-Urban Access Programme
EXP-1890 · Expanded synthetic participant 1890Site C — Rural Outreach Programme
EXP-1891 · Expanded synthetic participant 1891Site C — Rural Outreach Programme
EXP-1892 · Expanded synthetic participant 1892Site C — Rural Outreach Programme
EXP-1893 · Expanded synthetic participant 1893Site A — Urban Referral Hub
EXP-1894 · Expanded synthetic participant 1894Site C — Rural Outreach Programme
EXP-1895 · Expanded synthetic participant 1895Site B — Peri-Urban Access Programme
EXP-1896 · Expanded synthetic participant 1896Site E — Resource-Constrained Navigation Programme
EXP-1897 · Expanded synthetic participant 1897Site C — Rural Outreach Programme
EXP-1898 · Expanded synthetic participant 1898Site E — Resource-Constrained Navigation Programme
EXP-1899 · Expanded synthetic participant 1899Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1963
HPV DNA
2612
Cytology
722

Navigation activity

Barrier documented
919
Contact attempt
1473
Navigation intervention
412
Diagnostic booking
1275
Diagnostic visit
1260

Documented barriers

Contact difficulty
293
Transport difficulty
304
Appointment coordination
322

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.